Back to search

University of York

CRISPR Interference Screening and Pharmacological Targeting of Sodium Channels in Triple-Negative Breast Cancer Cells

Abstract

dc:description.abstract

Hypoxia is linked with more invasive forms of breast cancer, particularly triple negative breast cancer (TNBC). Elevated intratumoural sodium (Na+) level in patients correlates with disease severity and Na+ reduction predicts treatment response. Our in vivo data, using 23Na+ MRI, suggest that the majority of this Na+ is intracellular, implicating specific Na+ channels and transporters in its accumulation and regulation in the tumour microenvironment. While hypoxia has been shown to upregulate various Na+ channels, their combined involvement in hypoxia-driven breast cancer progression remains unclear. Here, we performed the first systematic screen to identify Na⁺ channels which support TNBC proliferation under hypoxia. Using a targeted CRISPR interference (CRISPRi) screen with a dCas9-KRAB transcriptional repression system, we repressed 181 Na+ channel and transporter genes in two TNBC cell lines, MDA-MB-231 and MDA-MB-468, cultured under normoxic or hypoxic conditions for 7 days. The screen identified hypoxia-specific depletion of guide RNAs (gRNAs) targeting SCN5A (Nav1.5), SLC10A5, SLC38A5, and SLC34A2 in MDA-MB-231 cells, and GRIN3A, SLC22A12, and SLC34A3 in MDA-MB-468 cells. FXYD5 was also exclusively depleted under hypoxia in both cell lines. To evaluate the therapeutic potential, we tested the Nav1.5 channel as a target in TNBC cells using propafenone, a clinically approved antiarrhythmic drug not previously studied in the cancer context. Electrophysiological analysis confirmed that propafenone (100 µM) significantly inhibited Na+ currents in MDA-MB-231 cells. Our findings highlight multiple Na+ transporters involved in TNBC proliferation under hypoxia, with SCN5A/Nav1.5 as a promising therapeutic target in hypoxic TNBC. These results support the potential repurposing of existing Na+ channel-targeting drugs to inhibit hypoxic TNBC progression.

Degree

thesis:*
Name dc:type.qualificationname
M.Sc by research
Level dc:type.qualificationlevel
masters
Grantor dc:publisher.institution
University of York
Year dc:date.issued
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Moore, Rachael
Advisors dc:contributor.advisor
  • Brackenbury, William
  • Holding, Andrew
ORCID person:identifier.orcid

Rights

Language dc:language.dcterms_iso639_2
eng

Identifiers

dc:identifier.*
Dc Identifier Grantnumber
MR/W006944/1

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Moore, Rachael. CRISPR Interference Screening and Pharmacological Targeting of Sodium Channels in Triple-Negative Breast Cancer Cells. masters thesis, University of York, 2025.